Found: 76
Select item for more details and to access through your institution.
RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 8, p. 854, doi. 10.3390/jpm14080854
- By:
- Publication type:
- Article
Resensitization in suspected penicillin allergy.
- Published in:
- Allergy, 2023, v. 78, n. 1, p. 214, doi. 10.1111/all.15508
- By:
- Publication type:
- Article
Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
- Published in:
- Allergy, 2023, v. 78, n. 1, p. 131, doi. 10.1111/all.15466
- By:
- Publication type:
- Article
COVID‐19 pandemic and environment: Not only air pollution.
- Published in:
- Allergy, 2022, v. 77, n. 12, p. 3699, doi. 10.1111/all.15394
- By:
- Publication type:
- Article
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID‐19?
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 961, doi. 10.1111/all.14593
- By:
- Publication type:
- Article
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments.
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 887, doi. 10.1111/all.14532
- By:
- Publication type:
- Article
COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
- Published in:
- Allergy, 2021, v. 76, n. 3, p. 871, doi. 10.1111/all.14516
- By:
- Publication type:
- Article
Allergen-specific immunotherapy and COVID-19: What happened?
- Published in:
- Allergologia & Immunopathologia, 2023, v. 51, n. 2, p. 148, doi. 10.15586/aei.v51i2.796
- By:
- Publication type:
- Article
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 853, doi. 10.3390/vaccines9080853
- By:
- Publication type:
- Article
Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. e96, doi. 10.1093/rheumatology/kead479
- By:
- Publication type:
- Article
Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Serum biomarkers of remodeling in severe asthma with fixed airway obstruction and the potential role of KL-6.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 10, p. 1679, doi. 10.1515/cclm-2022-1323
- By:
- Publication type:
- Article
The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 3, p. 307, doi. 10.1515/cclm-2021-1021
- By:
- Publication type:
- Article
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic.
- Published in:
- Biologics: Targets & Therapy, 2019, v. 13, p. 89, doi. 10.2147/BTT.S157183
- By:
- Publication type:
- Article
World Allergy Organization Anaphylaxis Guidance 2020 世界アレルギー機構 アナフィラキシーガイダンス2020.
- Published in:
- Arerugi: Japanese Journal of Allergology, 2021, v. 70, n. 9, p. 1211
- By:
- Publication type:
- Article
How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.
- Published in:
- Current Allergy & Asthma Reports, 2024, v. 24, n. 1, p. 11, doi. 10.1007/s11882-023-01118-6
- By:
- Publication type:
- Article
Relative Humidity and Its Impact on the Immune System and Infections.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9456, doi. 10.3390/ijms24119456
- By:
- Publication type:
- Article
IL-33 and the Cytokine Storm in COVID-19: From a Potential Immunological Relationship towards Precision Medicine.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14532, doi. 10.3390/ijms232314532
- By:
- Publication type:
- Article
Sex in Respiratory and Skin Allergies.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2019, v. 56, n. 3, p. 322, doi. 10.1007/s12016-017-8661-0
- By:
- Publication type:
- Article
Ranking in importance of allergen extract characteristics for sublingual immunotherapy by Italian specialists.
- Published in:
- Allergy & Asthma Proceedings, 2014, v. 35, n. 1, p. 43, doi. 10.2500/aap.2013.34.3721
- By:
- Publication type:
- Article
Biologics for Eosinophilic Granulomatosis With Polyangiitis—One Size Does Not Fit All: Comment on the Article by Canzian et al.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 425, doi. 10.1007/s40259-024-00653-6
- By:
- Publication type:
- Article
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.
- Published in:
- BioDrugs, 2022, v. 36, n. 4, p. 443, doi. 10.1007/s40259-022-00536-8
- By:
- Publication type:
- Article
Rediscovering Allergic Rhinitis: The Use of a Novel mHealth Solution to Describe and Monitor Health-Related Quality of Life in Elderly Patients.
- Published in:
- International Archives of Allergy & Immunology, 2022, v. 183, n. 11, p. 1178, doi. 10.1159/000525595
- By:
- Publication type:
- Article
The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study.
- Published in:
- International Archives of Allergy & Immunology, 2019, v. 178, n. 4, p. 333, doi. 10.1159/000495305
- By:
- Publication type:
- Article
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 3, p. 507, doi. 10.3390/diagnostics11030507
- By:
- Publication type:
- Article
Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02918-9
- By:
- Publication type:
- Article
The Clinical Characteristics of Respiratory Allergy in Immigrants in Northern Italy.
- Published in:
- International Archives of Allergy & Immunology, 2008, v. 147, n. 3, p. 231, doi. 10.1159/000142046
- By:
- Publication type:
- Article
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multidisciplinary management of type 2 inflammatory diseases.
- Published in:
- Multidisciplinary Respiratory Medicine, 2022, v. 17, p. 10, doi. 10.4081/mrm.2022.813
- By:
- Publication type:
- Article
Multidisciplinary management of type 2 inflammatory diseases.
- Published in:
- Multidisciplinary Respiratory Medicine, 2022, v. 17, p. 141, doi. 10.4081/mrm.2022.813
- By:
- Publication type:
- Article
Reslizumab and eosinophilic Asthma: One Step Closer to Precision Medicine?
- Published in:
- Frontiers in Immunology, 2017, v. 8, p. 1, doi. 10.3389/fimmu.2017.00242
- By:
- Publication type:
- Article
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 273, doi. 10.2147/JAA.S438981
- By:
- Publication type:
- Article
Diagnosis and Management of Allergic Rhinitis in Asthmatic Children.
- Published in:
- Journal of Asthma & Allergy, 2023, v. 16, p. 45, doi. 10.2147/JAA.S281439
- By:
- Publication type:
- Article
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm<sup>3</sup>: A Post Hoc Analysis from the ANANKE Study.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 1593, doi. 10.2147/JAA.S383012
- By:
- Publication type:
- Article
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy.
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 1011, doi. 10.2147/JAA.S309740
- By:
- Publication type:
- Article
Uncontrolled Asthma: Unmet Needs in the Management of Patients.
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 457, doi. 10.2147/JAA.S260604
- By:
- Publication type:
- Article
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry.
- Published in:
- Journal of Asthma & Allergy, 2020, v. 13, p. 599, doi. 10.2147/JAA.S274245
- By:
- Publication type:
- Article
Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab.
- Published in:
- Biomedicines, 2024, v. 12, n. 5, p. 960, doi. 10.3390/biomedicines12050960
- By:
- Publication type:
- Article
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 437, doi. 10.3390/biomedicines11020437
- By:
- Publication type:
- Article
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies.
- Published in:
- Biomedicines, 2021, v. 9, n. 9, p. 1163, doi. 10.3390/biomedicines9091163
- By:
- Publication type:
- Article
Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.
- Published in:
- Clinical & Translational Allergy, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13601-015-0060-0
- By:
- Publication type:
- Article
Minimal clinically important difference for asthma endpoints: an expert consensus report.
- Published in:
- European Respiratory Review, 2020, v. 29, n. 156, p. 1, doi. 10.1183/16000617.0137-2019
- By:
- Publication type:
- Article
Minimal clinically important difference for asthma endpoints: an expert consensus report.
- Published in:
- European Respiratory Review, 2020, v. 29, n. 156, p. 1, doi. 10.1183/16000617.0137-2019
- By:
- Publication type:
- Article
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.
- Published in:
- Allergy, 2020, v. 75, n. 6, p. 1460, doi. 10.1111/all.14135
- By:
- Publication type:
- Article
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real‐life observation.
- Published in:
- Allergy, 2019, v. 74, n. 12, p. 2539, doi. 10.1111/all.13937
- By:
- Publication type:
- Article
Budget impact analysis sull'introduzione del dispositivo di telemonitoraggio Turbo+ nella gestione dei pazienti asmatici in Italia.
- Published in:
- Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 58, doi. 10.33393/grhta.2022.2290
- By:
- Publication type:
- Article